KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Liabilities and Shareholders Equity (2016 - 2025)

CareDx (CDNA) has disclosed Liabilities and Shareholders Equity for 13 consecutive years, with $413.2 million as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 15.85% to $413.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 billion through Dec 2025, down 5.71% year-over-year, with the annual reading at $413.2 million for FY2025, 15.85% down from the prior year.
  • Liabilities and Shareholders Equity hit $413.2 million in Q4 2025 for CareDx, down from $432.3 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $566.6 million in Q4 2021 to a low of $413.2 million in Q4 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $504.1 million across 5 years, with a median of $508.0 million in 2023.
  • Biggest five-year swings in Liabilities and Shareholders Equity: skyrocketed 245.2% in 2021 and later decreased 15.85% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $566.6 million in 2021, then dropped by 4.17% to $543.0 million in 2022, then fell by 14.03% to $466.8 million in 2023, then increased by 5.19% to $491.0 million in 2024, then decreased by 15.85% to $413.2 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for CDNA at $413.2 million in Q4 2025, $432.3 million in Q3 2025, and $444.3 million in Q2 2025.